Ancillary Effects of Oral Naloxegol (Movantik)

Trial Profile

Ancillary Effects of Oral Naloxegol (Movantik)

Phase of Trial: Phase IV

Latest Information Update: 22 Jan 2018

At a glance

  • Drugs Naloxegol (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jan 2018 Status changed from not yet recruiting to recruiting.
    • 26 Oct 2017 Planned initiation date changed from 1 Aug 2017 to 1 Oct 2017.
    • 03 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top